Share Search
Visit the Share Search
Solvonis Therap Accounts Summary
| Date of Accounts | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 |
| Revenue | n/a | 0.59 | 0.54 | 0.22 | 0.52 |
| Operating Profit / Loss | -1.38 | -3.12 | -2.70 | -0.95 | -0.44 |
| Net Interest | -0.06 | n/a | n/a | -0.01 | -0.01 |
| Pre Tax Profit | -1.45 | -3.12 | -2.71 | -0.95 | -0.45 |
| Post Tax Profit | -1.45 | -3.12 | -2.71 | -0.95 | -0.45 |
| Profit for the Period | -1.59 | -3.12 | -2.70 | -0.95 | -0.45 |
| Equity Holders of Parent Company | -1.59 | -3.12 | -2.70 | -0.95 | -0.45 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Earnings per Share (Diluted) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Earnings per Share (Adjusted) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Earnings per Share (Diluted) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Earnings per Share (Adjusted) | -0.12p | -3.00p | -2.61p | -1.36p | -0.65p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 |
| Non-Current Assets | |||||
| Intangible Assets | 2.09 | 2.07 | 2.07 | 2.07 | 2.07 |
| Property, Plant and Equipment | n/a | 0.04 | 0.70 | 0.31 | 0.36 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | 0.30 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Non-Current Assets | 2.39 | 2.12 | 2.78 | 2.39 | 2.44 |
| Current Assets | |||||
| Inventories | n/a | 0.05 | 0.19 | n/a | n/a |
| Trade and Other Receivables | 0.06 | 0.11 | 0.33 | 0.14 | 0.09 |
| Cash at Bank and in Hand | 0.76 | 0.15 | 1.64 | 0.60 | 0.04 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 0.82 | 0.31 | 2.16 | 0.74 | 0.13 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 3.20 | 2.43 | 4.94 | 3.13 | 2.57 |
| Current Liabilities | |||||
| Borrowings | n/a | 0.01 | 0.00 | 0.96 | 0.65 |
| Other Current Liabilities | 0.12 | 0.37 | 0.36 | 1.36 | 0.67 |
| Total Current Liabilities | 0.12 | 0.39 | 0.37 | 2.32 | 1.32 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | 0.02 | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | 0.02 | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | 0.02 | 0.02 | n/a | n/a |
| Net Assets | 3.08 | 2.03 | 4.55 | 0.81 | 1.25 |
| Capital and Reserves | |||||
| Share Capital | 2.23 | 0.04 | 0.04 | 0.01 | 0.01 |
| Share Premium Account | 7.36 | 7.00 | 7.00 | 0.94 | 0.94 |
| Other Reserves | 4.04 | 3.95 | 3.36 | 3.00 | 2.48 |
| Retained Earnings | -10.55 | -8.96 | -5.84 | -3.14 | -2.19 |
| Shareholders Funds | 3.08 | 2.03 | 4.55 | 0.81 | 1.25 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 3.08 | 2.03 | 4.55 | 0.81 | 1.25 |
| 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | |
| Operating Margin | n/a% | -531.01% | -498.34% | -431.96% | -85.38% |
| Return on Capital Employed | -138.86% | 10,389.98% | -107.70% | 317.45% | 265.87% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 0.04p | n/ap | 0.11p | -0.06p | -0.04p |